These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34255858)

  • 1. Longitudinal motor function in proximal versus distal DMD pathogenic variants.
    Thangarajh M; Bello L; Gordish-Dressman H;
    Muscle Nerve; 2021 Oct; 64(4):467-473. PubMed ID: 34255858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modifiers of respiratory function in Duchenne muscular dystrophy.
    Bello L; D'Angelo G; Villa M; Fusto A; Vianello S; Merlo B; Sabbatini D; Barp A; Gandossini S; Magri F; Comi GP; Pedemonte M; Tacchetti P; Lanzillotta V; Trucco F; D'Amico A; Bertini E; Astrea G; Politano L; Masson R; Baranello G; Albamonte E; De Mattia E; Rao F; Sansone VA; Previtali S; Messina S; Vita GL; Berardinelli A; Mongini T; Pini A; Pane M; Mercuri E; Vianello A; Bruno C; Hoffman EP; Morgenroth L; Gordish-Dressman H; McDonald CM; ; Pegoraro E
    Ann Clin Transl Neurol; 2020 May; 7(5):786-798. PubMed ID: 32343055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Duchenne Muscular Dystrophy: Safety and Feasibility Study in India.
    Rajput BS; Chakrabarti SK; Dongare VS; Ramirez CM; Deb KD
    J Stem Cells; 2015; 10(2):141-56. PubMed ID: 27125141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study.
    Clemens PR; Rao VK; Connolly AM; Harper AD; Mah JK; McDonald CM; Smith EC; Zaidman CM; Nakagawa T; ; Hoffman EP
    J Neuromuscul Dis; 2023; 10(3):439-447. PubMed ID: 37005891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.
    Yamamoto T; Awano H; Zhang Z; Sakuma M; Kitaaki S; Matsumoto M; Nagai M; Sato I; Imanishi T; Hayashi N; Matsuo M; Iijima K; Saegusa J
    Circ Genom Precis Med; 2018 Jan; 11(1):e001782. PubMed ID: 29874176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
    Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
    Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central nervous system involvements in Duchenne/Becker muscular dystrophy].
    Kumagai T; Miura K; Ohki T; Matsumoto A; Miyazaki S; Nakamura M; Ochi N; Takahashi O
    No To Hattatsu; 2001 Nov; 33(6):480-6. PubMed ID: 11725514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted structural connectome and neurocognitive functions in Duchenne muscular dystrophy: classifying and subtyping based on Dp140 dystrophin isoform.
    Preethish-Kumar V; Shah A; Polavarapu K; Kumar M; Safai A; Vengalil S; Nashi S; Deepha S; Govindaraj P; Afsar M; Rajeswaran J; Nalini A; Saini J; Ingalhalikar M
    J Neurol; 2022 Apr; 269(4):2113-2125. PubMed ID: 34505932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.
    Bello L; Morgenroth LP; Gordish-Dressman H; Hoffman EP; McDonald CM; Cirak S;
    Neurology; 2016 Jul; 87(4):401-9. PubMed ID: 27343068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.
    Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP
    Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CINRG Becker Natural History Study: Baseline characteristics.
    Clemens PR; Niizawa G; Feng J; Florence J; DʼAlessandro AS; Morgenroth LP; Gorni K; Guglieri M; Connolly A; Wicklund M; Bertorini T; Mah JK; Thangarajh M; Smith E; Kuntz N; McDonald CM; Henricson EK; Upadhyayula S; Byrne B; Manousakis G; Harper A; Bravver E; Iannaccone S; Spurney C; Cnaan A; Gordish-Dressman H;
    Muscle Nerve; 2020 Sep; 62(3):369-376. PubMed ID: 32564389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.
    Ricotti V; Jägle H; Theodorou M; Moore AT; Muntoni F; Thompson DA
    Eur J Hum Genet; 2016 Apr; 24(4):562-8. PubMed ID: 26081639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
    Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
    Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dp71 and intellectual disability in Indonesian patients with Duchenne muscular dystrophy.
    Iskandar K; Triono A; Sunartini ; Dwianingsih EK; Indraswari BW; Kirana IR; Ivana G; Sutomo R; Patria SY; Herini ES; Gunadi
    PLoS One; 2022; 17(10):e0276640. PubMed ID: 36315559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.
    Bello L; Flanigan KM; Weiss RB; ; Spitali P; Aartsma-Rus A; Muntoni F; Zaharieva I; Ferlini A; Mercuri E; Tuffery-Giraud S; Claustres M; Straub V; Lochmüller H; Barp A; Vianello S; Pegoraro E; Punetha J; Gordish-Dressman H; Giri M; McDonald CM; Hoffman EP;
    Am J Hum Genet; 2016 Nov; 99(5):1163-1171. PubMed ID: 27745838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular Dystrophy.
    Fang Y; McDonald CM; Clemens PR; Gordish HD; Illei K; Hoffman EP; ; Dang UJ
    J Neuromuscul Dis; 2023; 10(3):349-364. PubMed ID: 36806514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.
    Preethish-Kumar V; Shah A; Kumar M; Ingalhalikar M; Polavarapu K; Afsar M; Rajeswaran J; Vengalil S; Nashi S; Thomas PT; Sadasivan A; Warrier M; Nalini A; Saini J
    AJNR Am J Neuroradiol; 2020 Jul; 41(7):1271-1278. PubMed ID: 32616576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.
    Taylor PJ; Betts GA; Maroulis S; Gilissen C; Pedersen RL; Mowat DR; Johnston HM; Buckley MF
    PLoS One; 2010 Jan; 5(1):e8803. PubMed ID: 20098710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Self-Reported Behavioral and Learning Concerns and DMD Isoforms in Duchenne Muscular Dystrophy.
    Counterman KJ; Fatovic K; Good DC; Martin AS; Dasgupta S; Anziska Y
    J Neuromuscul Dis; 2022; 9(6):757-764. PubMed ID: 36245385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.